拥护 发表于 2025-3-26 22:41:36

http://reply.papertrans.cn/15/1410/140960/140960_31.png

Ejaculate 发表于 2025-3-27 04:57:47

http://reply.papertrans.cn/15/1410/140960/140960_32.png

同步左右 发表于 2025-3-27 07:56:15

The Graph Programming Language GP vascular endothelial growth factor (VEGF)-tyrosine kinase inhibitors (TKIs) such as sunitinib, pazopanib, and cabozantinib was considered the predominant and preferred frontline treatment options. However, combination treatments including doublet PD-1/L1 and CTLA-4 inhibitor ipilimumab immune check

consolidate 发表于 2025-3-27 11:20:31

More Than 1700 Years of Word Equations,rapy. Various models have been developed to predict the risk of postoperative recurrence based on clinical and pathologic features of the primary tumor. Novel gene-based signatures have also been investigated to further improve these predictive nomograms. Patients at high risk of recurrence may be o

Strength 发表于 2025-3-27 16:42:21

http://reply.papertrans.cn/15/1410/140960/140960_35.png

bromide 发表于 2025-3-27 18:09:25

http://reply.papertrans.cn/15/1410/140960/140960_36.png

社团 发表于 2025-3-28 01:34:57

http://reply.papertrans.cn/15/1410/140960/140960_37.png

LVAD360 发表于 2025-3-28 04:45:51

http://reply.papertrans.cn/15/1410/140960/140960_38.png

骚扰 发表于 2025-3-28 08:58:49

https://doi.org/10.1007/978-3-642-40663-8tes, in the year 2021, the estimated number of new cases and the estimated deaths attributed to this cancer were 83,730 and 17,200, respectively . The incidence of bladder cancers is increasing, more so in developed countries. The incidence of new bladder cases in India was 25,873 in the year 202

BALK 发表于 2025-3-28 12:06:58

Lecture Notes in Computer ScienceBC is not a single entity and represents a clinically and pathologically variable spectrum of superficial bladder cancer. The most common presentation is with gross visible hematuria and the initial workup involves cross-sectional imaging with contrast for evaluation of the upper urinary tract, urin
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: A Guide to Management of Urological Cancers; Prabhjot Singh,Brusabhanu Nayak,Sridhar Panaiyadiy Book 2023 The Editor(s) (if applicable) an